Claims for Patent: 6,444,878

Summary for Patent: 6,444,878

Title:	Method of plant selection using glucosamine-6-phosphate deaminase
Abstract:	A selection method for selecting from a population of plant cells one or more genetically transformed plant cells is described. In the method, the population of plant cells includes selectable genetically transformed plant cells and possible non-transformed plant cells. Each of the selectable genetically transformed plant cells comprises a first expressible nucleotide sequence and optionally a second expressible nucleotide sequence. In the method, a component or a metabolic derivative thereof when present in a low concentration in a medium is a nutrient for both the selectable genetically transformed plant cells and the non-transformed plant cells. In the method, the component or the metabolic derivative thereof when present in a high concentration in a medium is toxic to the non-transformed plant cells. The first nucleotide sequence codes for a gene product having glucosamine-6-phosphate deaminase activity which is capable of converting the component or the metabolic derivative thereof when present in a high concentration in a medium to a nutrient for the selectable genetically transformed plant cells. The method includes the step of introducing the population of plant cells to a medium, wherein the medium includes a high concentration of the component or the metabolic derivative thereof. In the method, the component or the metabolic derivative thereof is a source of both carbohydrate and nitrogen for the selectable genetically transformed plant cells.
Inventor(s):	Donaldson; Iain A. (Tinglev, DK), Bojsen; Kirsten (Allerod, DK), Jorgensen; Kirsten (Guldborg, DK), Jorsboe; Morten (Nykobing Falster, DK)
Assignee:	Danisco A/S (Copenhagen, DK)
Application Number:	09/367,293
Patent Claims:	1. A selection method for selecting genetically transformed plant cells from a population of plant cells, comprising: transforming a population of plant cells with an expressible nucleotide sequence having at least 75% identity to SEQ ID NO: 1 and which encodes an enzyme having glucosamine-6-phosphate deaminase activity that converts a component or a metabolic derivative thereof when present in a high concentration in a medium into a nutrient, thereby producing a population of genetically transformed and non-transformed cells; introducing said population of plant cells to a medium comprising said component or metabolic derivative thereof, wherein the component or the metabolic derivative thereof is present in said medium in a high concentration and is toxic to said non-transformed plant cells and is a source of both carbohydrate and nitrogen for the selectable, genetically transformed plant cells or if a portion of the component serves as a metabolic substrate and is metabolically converted to a derivatized substrate, then that derivatized substrate provides an allosteric effect on the gene product; and culturing said plant cells thereby selecting at least a portion of said transformed plant cells over said non-transformed plant cells; and, wherein said enzyme having glucosamine-6-phosphate deaminase activity converts glucosamine-6-phosphate to fructose-6-phosphate. 2. The selection method of claim 1, wherein the population of cells is further transformed with a second expressible nucleotide sequence. 3. The selection method of claim 1, wherein said medium comprises said high concentration at a concentration greater than about 3.0 g/l. 4. The selection method of claim 1, wherein said component or metabolic derivative comprises a chemical group selected from the group consisting of an amine group and a phosphate group. 5. The selection method of claim 4, wherein said component is glucosamine. 6. The selection method of claim 4, wherein said metabolic derivative is glucosamine-6-phosphate. 7. The selection method of claim 1, wherein the expressible nucleotide sequence comprises an intron. 8. The selection method of claim 1, wherein the enzyme glucosamine-6-phosphate deaminase has the amino acid sequence shown as SEQ ID No. 3 or a sequence having at least 75% identity to SEQ ID No. 3. 9. The selection method of claim 1, wherein the enzyme glucosamine-6-phosphate deaminase is encoded by either the nucleotide sequence shown as SEQ ID No. 1 or a sequence having at least 75% identity to SEQ ID No:1 or the nucleotide sequence shown as SEQ ID No. 2. 10. The selection method of claim 1, wherein the method is carried out in vitro. 11. A composition comprising a population of transformed and non-transformed plant cells, said transformed plant cells being transformed with an expressible nucleotide sequence having at least 75% identity to SEQ ID NO: 1 and which encodes an enzyme having glucosamine-6-phosphate deaminase activity which converts a component or a metabolic derivative thereof into a nutrient, and a medium comprising said component or metabolic derivative thereof, wherein the component or the metabolic derivative thereof is present in said medium in a high concentration and is toxic to said non-transformed plant cells; and, wherein said enzyme having glucosamine-6-phosphate deaminase activity converts glucosamine-6-phosphate to fructose-6-phosphate. 12. The composition of claim 11, wherein the medium comprises glucosamine or glucosamine-6-phosphate. 13. The composition of claim 11, wherein the enzyme glucosamine-6-phosphate deaminase has the amino acid sequence shown as SEQ ID No. 3 or a sequence having at least 75% identity to SEQ ID No. 3. 14. The composition of claim 11, wherein the expressible nucleotide sequence has either the nucleotide sequence shown as SEQ ID No. 1 or a sequence having at least 75% identity to SEQ ID No: 1 and encoding glucosamine-6-phosphate deaminase, or the nucleotide sequence shown as SEQ ID No. 2. 15. A construct for genetically transforming a non-transformed plant cell to produce a selectable genetically transformed plant cell, said construct comprising: a plant promoter operably linked to an expressible nucleotide sequence encoding a glucosamine-6-phosphate deaminase gene product and having at least 75% identity to SEQ ID NO: 1; and, wherein said glucosamine-6-phosphate deaminase gene product converts glucosamine-6-phosphate to fructose-6-phosphate. 16. The construct of claim 15, wherein the enzyme glucosamine-6-phosphate deaminase has the amino acid sequence shown as SEQ ID No. 3 or a sequence having at least 75% identity to SEQ ID No. 3. 17. The construct of claim 15, wherein the enzyme glucosamine-6-phosphate deaminase is encoded by either the nucleotide sequence shown as SEQ ID No. 1 or a sequence having at least 75% identity to SEQ ID No: 1 or the nucleotide sequence shown as SEQ ID No. 2. 18. A kit comprising the construct of claim 15 and a component which is either a substrate for the glucosamine-6-phosphate deaminase or is a metabolic precursor to such a substrate. 19. A transgenic plant produced from a cell transformed with an expressible nucleotide sequence having at least 75% identity to SEQ ID NO: 1 and encoding an enzyme having glucosamine-6-phosphate deaminase activity. 20. The plant of claim 19, wherein said plant is selected from the group consisting of gourd, potato and maize. 21. An E. coli strain selected from the group consisting of NCIMB 40852, NCIMB 40853, and NCIMB 40854. 22. An isolated or purified polynucleotide having a sequence which comprises SEQ ID No: 2. 23. The selection method of claim 9, wherein the sequence having at least 75% identity to SEQ ID NO: 1 further comprises an intron. 24. The composition of claim 14, wherein the sequence having at least 75% identity to SEQ ID NO: 1 further comprises an intron. 25. The construct of claim 17, wherein the sequence having at least 75% identity to SEQ ID NO: 1 further comprises an intron.

Details for Patent 6,444,878

Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Merck Sharp & Dohme Corp.	INTRON A	interferon alfa-2b	For Injection	103132	06/04/1986		2017-02-07
Merck Sharp & Dohme Corp.	INTRON A	interferon alfa-2b	For Injection	103132			2017-02-07
Merck Sharp & Dohme Corp.	INTRON A	interferon alfa-2b	Injection	103132			2017-02-07